ResMed (RMD) Tops Q4 EPS by 2c, Beats on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $190.70 +1.19%
Revenue Growth %: +13.1%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +13.1%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $556.7 million versus the consensus estimate of $555.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
